Skip to main content
Skip to footer
Contact Us
We are taking you to another website now.
TCS Helps AstraZeneca Focus on Core Tasks
Vita M Petrik, Interface Lead, describe how a partnership with TCS helped the company focus on core activities centered around patient safety. This association also improved its productivity by streamlining its pharmacovigilance processes.
Play Video
Error: unable to play the video
volume button Opens full screen
Biopharmaceutical Innovation Research
Patient Safety Innovative Medicines

“One of the unique things about working with TCS is that you really feel that joint sense of commitment and ownership.” 

AstraZeneca, Vita M Petrik, Interface Lead – Patient Safety

AstraZeneca is a global, innovation-driven biopharmaceutical company with a presence in more than 100 countries and innovative medicines used by millions of patients worldwide.

It selected TCS as a partner to focus on its core activities and enhance patient safety.

Experience Results

Vita points out how TCS helped AstraZeneca with the standardization of the pharmacovigilance process. TCS relocated and consolidated seven case handling sites across the globe to two sites, providing consistency, something that regulators seek.

Experience Partnership

Vita highlights that the partnership shared with TCS has been a unique experience and not a typical client-vendor relationship. TCS and AstraZeneca share equal accountability and responsibility toward achieving joint objectives.

Experience Leadership

Vita explains that one of its reasons for outsourcing was to increase productivity, which did not meet the industry standards. As a result of its partnership with TCS, productivity in case handling has more than doubled. TCS also helped AstraZeneca centralize its processes, bringing about consistency in working with all its providers as well as regulators.

More Like This

Thank you for downloading

Your opinion counts! Let us know what you think by choosing one option below.